Table 1.

Demographics and clinical characteristics of patients with CRE isolates.

Characteristic	No. (%) (n = 61)
Female	25 (41)
Age, median (range)	56 (1–86)
Inpatient	34 (55.7)
Comorbidities
Immunosuppression	33 (54)
Solid-tumor malignancy	13 (21.3)
Solid-organ transplant	11 (18)
Hematological malignancy	8 (13.1)
HSCT	1 (1.6)
HIV-AIDS	0 (0)
Diabetes	12 (19.6)
Congestive heart failure	10 (16.4)
Cirrhosis	4 (6.5)
Structural lung disease	4 (6.5)
Major surgery within 30 days	4 (6.5)
Prematurity	1 (1.6)
No comorbidities	7 (11.5)
Specimen source
Urinary tract	24 (39.3)
Blood	12 (19.7)
Intra-abdominal	8 (13.1)
Lower respiratory tract	7 (11.5)
Osteoarticular	4 (6.5)
Biliary tract	2 (3.3)
Skin soft tissue	2 (3.3)
Genital	1 (1.6)
Respiratory sinus	1 (1.6)

HSCT = hematopoietic stem cell transplant.